PI3Kα-IN-27

PI3Kα-IN-27 (Compound 50b) is an orally active PI3K-α inhibitor with an IC50 of 40 nM. It effectively inhibits PAK3, p110α, phosphorylated mTOR, and phosphorylated ERK1/2. PI3Kα-IN-27 can induce early apoptosis (Apoptosis) and demonstrates anticancer activity against pancreatic, lung, and breast cancers.